Annexin A1'containing extracellular vesicles and polymeric nanoparticles promote epithelial wound repair

Journal of Clinical Investigation

Volumn 125, Issue 3, 2015, Pages 1215-1227

  Leoni, Giovanna ^a,b   Neumann, Philipp Alexander ^a,c   Kamaly, Nazila ^d   Quiros, Miguel ^a   Nishio, Hikaru ^a   Jones, Hefin R ^e   Sumagin, Ronen ^a   Hilgarth, Roland S ^a   Alam, Ashfaqul ^a   Fredman, Gabrielle ^f   Argyris, Ioannis ^c   Rijcken, Emile ^c   Kusters, Dennis ^g   Reutelingsperger, Chris ^g   Perretti, Mauro ^e   Parkos, Charles A ^a,h   Farokhzad, Omid C ^d   Neish, Andrew S ^a   Nusrat, Asma ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^f Och Spine at New York Presbyterian Hospitals   (United States)

^g MAASTRICHT UNIVERSITY   (Netherlands)

^h UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAM10 ENDOPEPTIDASE; CD151 ANTIGEN; CD9 ANTIGEN; COLLAGEN TYPE 4; DEXTRAN SULFATE; GELATINASE B; LIPOCORTIN 1; LIPOCORTIN 5; NANOPARTICLE; ANNEXIN A1 PEPTIDE (2-26); ANTIINFLAMMATORY AGENT; PEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM CELL LEVEL; CELL MEMBRANE; CELL VACUOLE; CONTROLLED STUDY; CROHN DISEASE; DRUG MECHANISM; EXPERIMENTAL COLITIS; EXTRACELLULAR SPACE; EXTRACELLULAR VESICLE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOGOLD LABELING; INFLAMMATORY BOWEL DISEASE; INTESTINE EPITHELIUM CELL; MOUSE; NONHUMAN; POLYMERIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; SIGNAL TRANSDUCTION; ULCERATIVE COLITIS; WOUND CLOSURE; WOUND HEALING; ANIMAL; BLOOD; CELL LINE; COLITIS; DRUG EFFECTS; EXOSOME; INTESTINE MUCOSA; KNOCKOUT MOUSE; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; ANNEXIN A1; ANTI-INFLAMMATORY AGENTS; CELL LINE; COLITIS; EXOSOMES; HUMANS; INTESTINAL MUCOSA; MICE, KNOCKOUT; NANOPARTICLES; PEPTIDES; WOUND HEALING;

EID: 84924066805     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI76693     Document Type: Article

References (63)

1. Koch S, Nusrat A. The life and death of epithelia during inflammation: lessons learned from the gut. Annu Rev Pathol. 2012;7:35-60.
2. Serhan CN, Dalli J, Colas RA, Winkler JW, Chiang N. Protectins and maresins: new pro-resolving families of mediators in acute inflammation and resolution bioactive metabolome [published online ahead of print August 17, 2014]. Biochim Biophys Acta. doi:10.1016/j.bbalip.2014.08.006.
3. Serhan CN. Pro-resolving lipid mediators are leads for resolution physiology. Nature. 2014;510(7503):92-101.
4. Babbin BA, et al. Annexin I regulates SKCO-15 cell invasion by signaling through formyl peptide receptors. J Biol Chem. 2006; 281(28):19588-19599.
5. Martin GR, Perretti M, Fl ower RJ, Wallace JL. Annexin-1 modulates repair of gastric mucosal injury. Am J Physiol Gastrointest Liver Physiol. 2008;294(3):G764-G769.
6. Perretti M, D'Acquisto F. Annexin A1 and glucocorticoids as effectors of the resolution of inflammation. Nat Rev Immunol. 2009;9(1):62-70.
7. Leoni G, et al. Annexin A1, formyl peptide receptor, and NOX1 orchestrate epithelial repair. J Clin Invest. 2013;123(1):443-454.
8. Dalli J, Norling LV, Renshaw D, Cooper D, Leung KY, Perretti M. Annexin 1 mediates the rapid anti-inflammatory effects of neutrophil-derived microparticl es. Blood. 2008;112(6):2512-2519.
9. Dalli J, Serhan CN. Specific lipid mediator signatures of human phagocytes: microparticles stimulate macrophage efferocytosis and pro-resolving mediators. B lood. 2012;120(15):e60-e72.
10. Raposo G, Stoorvogel W. Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol. 2013;200(4):373-383.
11. Thery C, Zitvogel L, Amigorena S. Exosomes: composition, biogenesis and function. Nat Rev Immunol. 2002;2(8):569-579.
12. van Niel G, et al. Intestinal epithelial cells secrete exosome-like vesicles. Gastroenterology. 2001;121(2):337-349.
13. Cocucci E, Racchetti G, Meldolesi J. Shedding microvesicles: artefacts no more. Trends Cell Biol. 2009;19(2):43-51.
14. Caby MP, Lankar D, Vincendeau-Scherrer C, Raposo G, Bonnerot C. Exosomal-like vesicles are present in human blood plasma. Int Immunol. 2005;17(7):879-887.
15. Kamaly N,et al Development and in vivo efficacy of targeted polymeric inflammationresolving nanoparticles Proc Natl Acad Sci U S A. 2013 110 16 6506-6511.
16. Khokha R, Murthy A, Weiss A. Metalloproteinases and their natural inhibitors in inflammation and immunity. Nat Rev Immunol. 2013;13(9):649-665.
17. Trajkovic K, et al. C eramide triggers budding of exosome vesicles into multivesicular endosomes. Science. 2008;319(5867):1244-1247.
18. Escola JM, Kleijmeer MJ, Stoorvogel W, Griffith JM, Yoshie O, Geuze HJ. Selective enrichment of tetraspan proteins on the internal vesicles of multivesicular endosomes and on exosomes secreted by human B-lymphocytes. J Biol Chem. 1998; 273(32):20121-20127.
19. Bi GQ, Alderton JM, Steinhardt RA. Calciumregulated exocytosis is required for cell membrane resealing. J Cell Biol. 1995;131(6 pt 2):1747-1758.
20. Gerke V, Creutz CE, Moss SE. Annexins: linking Ca2+ signalling to membrane dynamics. Nat Rev Mol Cell Biol. 2005;6(6):449-461.
21. Fenteany G, Zhu S. Small-molecule inhibitors of actin dynamics and cell motility. Curr Top Med Chem. 2003;3(6):593-616.
22. Headland SE, Jones HR, D'Sa AS, Perretti M, Norling LV. Cutting-edge analysis of extracellular micropa rticles using ImageStream(X) imaging flow cytometry. Sci Rep. 2014;4:5237.
23. Babbin BA, et al. Annexin A1 regulates intestinal mucosal injury, inflammation, and repair. J Immunol. 2008;181(7):5035-5044.
24. McNeil AK, Rescher U, Gerke V, McNeil PL. Requirement for annexin A1 in plasma membrane repair. J Biol Chem. 2006;281(46):35202-35207.
25. Kundu K, Knight SF, Willett N, Lee S, Taylor WR, Murthy N. Hydrocyanines: a class of fluorescent sensors that can image reactive oxygen species in cell culture, tissue, and in vivo. Angew Chem Int Ed Engl. 2009;48(2):299-303.
26. Becker C, Fantini MC, Neurath MF. High resolution colonoscopy in live mice. Nat Protoc. 2006;1(6):2900-2904.
27. Moritz RL, et al. Micro-sequencing strategies for the human A33 antigen, a novel surface glycoprotein of human gastrointestinal epithelium. J Chromatogr A. 1998;798(1-2):91-101.
28. Buzas EI, György B, Nagy G, Falus A, Gay S. Emerging role of extracellular vesicles in inflammatory diseases. Nat Rev Rheumatol. 2014;10(6):356-364.
29. Vergnolle N, et al. Annexin 1 is secreted in situ during ulcerative colitis in humans. Inflamm Bowel Dis. 2004;10(5):584-592.
30. Wirtz S, Neufert C, Weigmann B, Neurath MF. Chemically induced mouse models of intestinal inflammation. Nat Protoc. 2007;2(3):541-546.
31. Chan JM, et al. Spatiotemporal controlled delivery of nanoparticles to injured vasculature. Proc Natl Acad Sci U S A. 2010;107(5):2213-2218.
32. Chassaing B, Srinivasan G, Delgado MA, Young AN, Gewirtz AT, Vijay-Kumar M. Fecal lipocalin 2, a sensitive and broadly dynamic non-invasive biomarker for intestinal in flammation. PLoS One. 2012;7(9):e44328.
33. Cordeiro JV, Jacinto A. The role of transcription-independent damage signals in the initiation of epithelial wound healing. Nat Rev Mol Cell Biol. 2013;14(4):249-262.
34. Spite M, Claria J, Serhan CN. Resolvins, specialized proresolving lipid mediators, and their potential roles in metabolic diseases. Cell Metab. 2014;19(1):21-36.
35. Abdulnour RE, et al. Maresin 1 biosynthesis during platelet-neutrophil interactions is organ-protective. Proc Natl Acad Sci U S A. 2014;111(46):16526-16531.
36. Buckley CD, Gilroy DW, Serhan CN. Proresolving lipid mediators and mechanisms in the resolution of acute inflammation. Immunity. 2014;40(3):315-327.
37. Fredman G, et al. Resolvin D1 limits 5-lipoxygenase nuclear localization and leukotriene B4 synthesis by inhibiting a calcium-Activated kinase pathway. Proc Natl Acad Sci U S A. 2014;111(40):14530-14535.
38. Ye RD, et al. International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family. Pharmacol Rev. 2009;61(2):119-161.
39. Aalberts M, et al. Identification of distinct populations of prosta somes that differentially express prostate stem cell antigen, annexin A1, and GLIPR2 in humans. Biol Reprod. 2012;86(3):82.
40. Van Lint P, Libert C. Chemokine and cytokine processing by matrix metallop roteinases and its effect on leukocyte migration and inflammation. J Leukoc Biol. 2007;82(6):1375-1381.
41. Brancaleone V, Dalli J, Bena S, Flower RJ, Cirino G, Perretti M. Evidence for an anti-inflammatory loop centered on polymorphonuclear leukocyte formyl peptide receptor 2/lipoxin A4 receptor and operative in the inflamed microvasculature. J Immunol. 2011;186(8):4905-4914.
42. Hayhoe RP 1, Kamal AM, Solito E, Flower RJ, Cooper D, Perretti M. Annexin 1 and its bioactive peptide inhibit neutrophil-endothelium interactions under flow: indication of distinct receptor involvement. Blood. 2006;107(5) :2123-2130.
43. Bena S, Brancaleone V, Wang JM, Perretti M, Flower RJ. Annexin A1 interaction with the FPR2/ALX receptor: identification of distinct domains and downstream associated signaling. J Biol Chem. 2012;287(29):24690-24697.
44. Cooray SN, et al. Ligand-specific conformational change of the G-protein-coupled receptor ALX/FPR2 determines proresolving functional responses. Proc Natl Acad Sci U S A. 2013;110(45):18232-18237.
45. Alam A, et al. Redox signaling regulates commensal-mediated mucosal homeostasis and restitution and requires formyl peptide receptor Mucosal Immunol. 2014;7(3):645-655.
46. Gronert K, Maheshwari N, Khan N, Hassan IR, Dunn M, Laniado Schwartzman M. A role for the mouse 12/15-lipoxygenase pathway in promoting epithelial wound healing and host defense. J Biol Chem. 2005;280( 15):15267-15278.
47. Perretti M, Flower RJ. Measurement of lipocortin 1 levels in murine peripheral blood leukocytes by flow cytometry: modulation by glucocorticoids and inflammation. Br J Pharmacol. 1996;118(3):605-610.
48. Vong L, et al. Annexin 1 cleavage in activated neutrophils: a pivotal role for proteinase J Biol Chem. 2007;282(41):29998-30004.
49. Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev Immunol. 2008;8(12):958-969.
50. Dalli J, et al. The novel 13S,14S-epoxy-maresin is convert ed by human macrophages to maresin 1 (MaR1), inhibits leukotriene A4 hydrolase (LTA4H), and shifts macrophage phenotype. FASEB J. 2013;27(7):2573-2583.
51. Serhan CN, et al. Macrophage proresolving mediator maresin 1 stimulates tissue regeneration and controls pain. FASEB J. 2012;26(4):1755-1765.
52. Norling LV, Spite M, Yang R, Flower RJ, Perretti M, Serhan CN. Cutting edge: Humanized nano-proresolving medicines mimic inflammation-resolution and enhance wound healing. J Immunol. 2011;186(10):5543-5547.
53. Baumgart DC, Sandborn WJ. Crohn's disease. Lancet. 2012;380(9853):1590-1605.
54. Ordás I, Eckmann L, Talamini M, Baumgart DC, Sandborn WJ. Ulcerative colitis. Lancet. 2012;380(9853):1606-1619.
55. Tauro BJ, Greening DW , Mathias RA, Mathivanan S, Ji H, Simpson RJ. Two distinct populations of exosomes are released from LIM1863 colon carcinoma cell-derived organoids. Mol Cell Proteomics. 2013;12(3):587-598.
56. Buzas EI,György B,Nagy G,Falus A,Gay S Emerging role of extracellular vesicles in inflammatory diseases Nat Rev Rheumatol. 2014 10 6 356-364
57. Ulbrich W, Lamprecht A. Targeted drug-delivery approaches by nanoparticulate carriers in the therapy of inflammatory diseases. J R Soc Interface. 2010;7(suppl 1):S55-S66.
58. Laroui H, et al. Nanomedicine in GI. Am J Physiol Gastrointest Liver Physiol. 2011;300(3):G371-G383.
59. Babbin BA, et al. Formyl peptide receptor-1 activation enhances intestinal epithelial cell restitution through phosphatidylinosit ol 3-kinasedependent activation of Rac1 and Cdc42. J Immunol. 2007;179(12):8112-8121.
60. Khounlotham M, et al. Compromised intestinal epithelial barrier induces adaptive immune compensation that protects from colitis. Immunity. 2012;37(3):563-573.
61. Nava P, et al. Interferon-? regulates intestinal epithelial homeostasis through converging ?-catenin signaling pathways. Immunity. 2010;32(3):392-402.
62. Thé ry C, Amigorena S, Raposo G, Clayton A. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr Protoc Cell Biol. 2006;Chapter 3:Unit 3.22.
63. Hannon R, et al. Aberrant inflammation and resistance to glucocorticoids in annexin 1-/-mouse. FASEB J. 2003;17(2):253-255.